154 related articles for article (PubMed ID: 19502558)
1. Silencing the myotrophin gene by RNA interference leads to the regression of cardiac hypertrophy.
Gupta S; Maitra R; Young D; Gupta A; Sen S
Am J Physiol Heart Circ Physiol; 2009 Aug; 297(2):H627-36. PubMed ID: 19502558
[TBL] [Abstract][Full Text] [Related]
2. Prevention of cardiac hypertrophy and heart failure by silencing of NF-kappaB.
Gupta S; Young D; Maitra RK; Gupta A; Popovic ZB; Yong SL; Mahajan A; Wang Q; Sen S
J Mol Biol; 2008 Jan; 375(3):637-49. PubMed ID: 18037434
[TBL] [Abstract][Full Text] [Related]
3. Blockade of NF-kappaB using IkappaB alpha dominant-negative mice ameliorates cardiac hypertrophy in myotrophin-overexpressed transgenic mice.
Young D; Popovic ZB; Jones WK; Gupta S
J Mol Biol; 2008 Sep; 381(3):559-68. PubMed ID: 18620706
[TBL] [Abstract][Full Text] [Related]
4. Influence of p53 in the transition of myotrophin-induced cardiac hypertrophy to heart failure.
Das B; Young D; Vasanji A; Gupta S; Sarkar S; Sen S
Cardiovasc Res; 2010 Aug; 87(3):524-34. PubMed ID: 20202977
[TBL] [Abstract][Full Text] [Related]
5. Activation of nuclear factor-kappaB is necessary for myotrophin-induced cardiac hypertrophy.
Gupta S; Purcell NH; Lin A; Sen S
J Cell Biol; 2002 Dec; 159(6):1019-28. PubMed ID: 12486112
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of nuclear factor κB regresses cardiac hypertrophy by modulating the expression of extracellular matrix and adhesion molecules.
Kumar S; Seqqat R; Chigurupati S; Kumar R; Baker KM; Young D; Sen S; Gupta S
Free Radic Biol Med; 2011 Jan; 50(1):206-15. PubMed ID: 21047552
[TBL] [Abstract][Full Text] [Related]
7. Myotrophin-kappaB DNA interaction in the initiation process of cardiac hypertrophy.
Gupta S; Sen S
Biochim Biophys Acta; 2002 May; 1589(3):247-60. PubMed ID: 12031792
[TBL] [Abstract][Full Text] [Related]
8. Nuclear co-translocation of myotrophin and p65 stimulates myocyte growth. Regulation by myotrophin hairpin loops.
Das B; Gupta S; Vasanji A; Xu Z; Misra S; Sen S
J Biol Chem; 2008 Oct; 283(41):27947-27956. PubMed ID: 18693253
[TBL] [Abstract][Full Text] [Related]
9. Cardiac overexpression of myotrophin triggers myocardial hypertrophy and heart failure in transgenic mice.
Sarkar S; Leaman DW; Gupta S; Sil P; Young D; Morehead A; Mukherjee D; Ratliff N; Sun Y; Rayborn M; Hollyfield J; Sen S
J Biol Chem; 2004 May; 279(19):20422-34. PubMed ID: 14970239
[TBL] [Abstract][Full Text] [Related]
10. Myotrophin in human heart failure.
O'Brien RJ; Loke I; Davies JE; Squire IB; Ng LL
J Am Coll Cardiol; 2003 Aug; 42(4):719-25. PubMed ID: 12932609
[TBL] [Abstract][Full Text] [Related]
11. Regulation of myotrophin gene by pressure overload and stretch.
Sil P; Gupta S; Young D; Sen S
Mol Cell Biochem; 2004 Jul; 262(1-2):79-89. PubMed ID: 15532712
[TBL] [Abstract][Full Text] [Related]
12. Myotrophin induces early response genes and enhances cardiac gene expression.
Mukherjee DP; McTiernan CF; Sen S
Hypertension; 1993 Feb; 21(2):142-8. PubMed ID: 8428777
[TBL] [Abstract][Full Text] [Related]
13. Myocardial cell death and regeneration during progression of cardiac hypertrophy to heart failure.
Sarkar S; Chawla-Sarkar M; Young D; Nishiyama K; Rayborn ME; Hollyfield JG; Sen S
J Biol Chem; 2004 Dec; 279(50):52630-42. PubMed ID: 15385543
[TBL] [Abstract][Full Text] [Related]
14. Characterization and functional significance of myotrophin: a gene with multiple transcripts.
Adhikary G; Gupta S; Sil P; Saad Y; Sen S
Gene; 2005 Jun; 353(1):31-40. PubMed ID: 15946807
[TBL] [Abstract][Full Text] [Related]
15. Increased protein kinase C activity in myotrophin-induced myocyte growth.
Sil P; Kandaswamy V; Sen S
Circ Res; 1998 Jun; 82(11):1173-88. PubMed ID: 9633917
[TBL] [Abstract][Full Text] [Related]
16. cDNA sequence and characterization of the gene that encodes human myotrophin/V-1 protein, a mediator of cardiac hypertrophy.
Anderson KM; Berrebi-Bertrand I; Kirkpatrick RB; McQueney MS; Underwood DC; Rouanet S; Chabot-Fletcher M
J Mol Cell Cardiol; 1999 Apr; 31(4):705-19. PubMed ID: 10329199
[TBL] [Abstract][Full Text] [Related]
17. NF-kappaB activation is required for adaptive cardiac hypertrophy.
Zelarayan L; Renger A; Noack C; Zafiriou MP; Gehrke C; van der Nagel R; Dietz R; de Windt L; Bergmann MW
Cardiovasc Res; 2009 Dec; 84(3):416-24. PubMed ID: 19620128
[TBL] [Abstract][Full Text] [Related]
18. Astragaloside IV protects against isoproterenol-induced cardiac hypertrophy by regulating NF-κB/PGC-1α signaling mediated energy biosynthesis.
Zhang S; Tang F; Yang Y; Lu M; Luan A; Zhang J; Yang J; Wang H
PLoS One; 2015; 10(3):e0118759. PubMed ID: 25738576
[TBL] [Abstract][Full Text] [Related]
19. Artemisinin, an anti-malarial agent, inhibits rat cardiac hypertrophy via inhibition of NF-κB signaling.
Xiong Z; Sun G; Zhu C; Cheng B; Zhang C; Ma Y; Dong Y
Eur J Pharmacol; 2010 Dec; 649(1-3):277-84. PubMed ID: 20863781
[TBL] [Abstract][Full Text] [Related]
20. Impairment of ultrastructure and cytoskeleton during progression of cardiac hypertrophy to heart failure.
Gupta A; Gupta S; Young D; Das B; McMahon J; Sen S
Lab Invest; 2010 Apr; 90(4):520-30. PubMed ID: 20157292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
